Loading...
A tertiary care experience with paclitaxel and cetuximab as palliative chemotherapy in platinum sensitive and nonsensitive in head and neck cancers
BACKGROUND: The combination of paclitaxel and cetuximab (PaCe) has led to an encouraging response rate in Phase 2 setting with limited toxicity. The aim of our study was to assess the efficacy of this regimen in our setting in platinum sensitive and nonsensitive patients. METHODS: This was a retrosp...
Na minha lista:
| Udgivet i: | South Asian J Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medknow Publications & Media Pvt Ltd
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5379885/ https://ncbi.nlm.nih.gov/pubmed/28413788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2278-330X.202558 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|